Supplementation of l-Alanyl-l-Glutamine and Fish Oil Improves Body Composition and Quality of Life in Patients With Chronic Heart Failure

Christina Wu, Tomoko S. Kato, Ruiping Ji, Cynthia Zizola, Danielle L. Brunjes, Yue Deng, Hirokazu Akashi, Hilary F. Armstrong, Peter J. Kennel, Tiffany Thomas, Daniel E. Forman, Jennifer Hall, Aalap Chokshi, Matthew N. Bartels, Donna Mancini, David Seres, P. Christian Schulze

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background - Skeletal muscle dysfunction and exercise intolerance are clinical hallmarks of patients with heart failure. These have been linked to a progressive catabolic state, skeletal muscle inflammation, and impaired oxidative metabolism. Previous studies suggest beneficial effects of ω-3 polyunsaturated fatty acids and glutamine on exercise performance and muscle protein balance. Methods and Results - In a randomized double-blind, placebo-controlled trial, 31 patients with heart failure were randomized to either l-alanyl-l-glutamine (8 g/d) and polyunsaturated fatty acid (6.5 g/d) or placebo (safflower oil and milk powder) for 3 months. Cardiopulmonary exercise testing, dual-energy x-ray absorptiometry, 6-minute walk test, hand grip strength, functional muscle testing, echocardiography, and quality of life and lateral quadriceps muscle biopsy were performed at baseline and at follow-up. Oxidative capacity and metabolic gene expression were analyzed on muscle biopsies. No differences in muscle function, echocardiography, 6-minute walk test, or hand grip strength and a nonsignificant increase in peak VO2 in the treatment group were found. Lean body mass increased and quality of life improved in the active treatment group. Molecular analysis revealed no differences in muscle fiber composition, fiber cross-sectional area, gene expression of metabolic marker genes (PGC1α, CPT1, PDK4, and GLUT4), and skeletal muscle oxidative capacity. Conclusions - The combined supplementation of l-alanyl-l-glutamine and polyunsaturated fatty acid did not improve exercise performance or muscle function but increased lean body mass and quality of life in patients with chronic stable heart failure. These findings suggest potentially beneficial effects of high-dose nutritional polyunsaturated fatty acids and amino acid supplementations in patients with chronic stable heart failure.

Original languageEnglish (US)
Pages (from-to)1077-1087
Number of pages11
JournalCirculation: Heart Failure
Volume8
Issue number6
DOIs
StatePublished - Nov 1 2015
Externally publishedYes

Fingerprint

alanylglutamine
Fish Oils
Body Composition
Hand Strength
Unsaturated Fatty Acids
Heart Failure
Quality of Life
Muscles
Exercise
Skeletal Muscle
Echocardiography
Placebos
Safflower Oil
Biopsy
Gene Expression
Muscle Proteins
Quadriceps Muscle
Glutamine
Powders
Milk

Keywords

  • echocardiography
  • heart failure
  • metabolism
  • muscle, skeletal
  • quality of life

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Supplementation of l-Alanyl-l-Glutamine and Fish Oil Improves Body Composition and Quality of Life in Patients With Chronic Heart Failure. / Wu, Christina; Kato, Tomoko S.; Ji, Ruiping; Zizola, Cynthia; Brunjes, Danielle L.; Deng, Yue; Akashi, Hirokazu; Armstrong, Hilary F.; Kennel, Peter J.; Thomas, Tiffany; Forman, Daniel E.; Hall, Jennifer; Chokshi, Aalap; Bartels, Matthew N.; Mancini, Donna; Seres, David; Schulze, P. Christian.

In: Circulation: Heart Failure, Vol. 8, No. 6, 01.11.2015, p. 1077-1087.

Research output: Contribution to journalArticle

Wu, C, Kato, TS, Ji, R, Zizola, C, Brunjes, DL, Deng, Y, Akashi, H, Armstrong, HF, Kennel, PJ, Thomas, T, Forman, DE, Hall, J, Chokshi, A, Bartels, MN, Mancini, D, Seres, D & Schulze, PC 2015, 'Supplementation of l-Alanyl-l-Glutamine and Fish Oil Improves Body Composition and Quality of Life in Patients With Chronic Heart Failure', Circulation: Heart Failure, vol. 8, no. 6, pp. 1077-1087. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002073
Wu, Christina ; Kato, Tomoko S. ; Ji, Ruiping ; Zizola, Cynthia ; Brunjes, Danielle L. ; Deng, Yue ; Akashi, Hirokazu ; Armstrong, Hilary F. ; Kennel, Peter J. ; Thomas, Tiffany ; Forman, Daniel E. ; Hall, Jennifer ; Chokshi, Aalap ; Bartels, Matthew N. ; Mancini, Donna ; Seres, David ; Schulze, P. Christian. / Supplementation of l-Alanyl-l-Glutamine and Fish Oil Improves Body Composition and Quality of Life in Patients With Chronic Heart Failure. In: Circulation: Heart Failure. 2015 ; Vol. 8, No. 6. pp. 1077-1087.
@article{7266e7bda2c148cca60d0d5a0527f846,
title = "Supplementation of l-Alanyl-l-Glutamine and Fish Oil Improves Body Composition and Quality of Life in Patients With Chronic Heart Failure",
abstract = "Background - Skeletal muscle dysfunction and exercise intolerance are clinical hallmarks of patients with heart failure. These have been linked to a progressive catabolic state, skeletal muscle inflammation, and impaired oxidative metabolism. Previous studies suggest beneficial effects of ω-3 polyunsaturated fatty acids and glutamine on exercise performance and muscle protein balance. Methods and Results - In a randomized double-blind, placebo-controlled trial, 31 patients with heart failure were randomized to either l-alanyl-l-glutamine (8 g/d) and polyunsaturated fatty acid (6.5 g/d) or placebo (safflower oil and milk powder) for 3 months. Cardiopulmonary exercise testing, dual-energy x-ray absorptiometry, 6-minute walk test, hand grip strength, functional muscle testing, echocardiography, and quality of life and lateral quadriceps muscle biopsy were performed at baseline and at follow-up. Oxidative capacity and metabolic gene expression were analyzed on muscle biopsies. No differences in muscle function, echocardiography, 6-minute walk test, or hand grip strength and a nonsignificant increase in peak VO2 in the treatment group were found. Lean body mass increased and quality of life improved in the active treatment group. Molecular analysis revealed no differences in muscle fiber composition, fiber cross-sectional area, gene expression of metabolic marker genes (PGC1α, CPT1, PDK4, and GLUT4), and skeletal muscle oxidative capacity. Conclusions - The combined supplementation of l-alanyl-l-glutamine and polyunsaturated fatty acid did not improve exercise performance or muscle function but increased lean body mass and quality of life in patients with chronic stable heart failure. These findings suggest potentially beneficial effects of high-dose nutritional polyunsaturated fatty acids and amino acid supplementations in patients with chronic stable heart failure.",
keywords = "echocardiography, heart failure, metabolism, muscle, skeletal, quality of life",
author = "Christina Wu and Kato, {Tomoko S.} and Ruiping Ji and Cynthia Zizola and Brunjes, {Danielle L.} and Yue Deng and Hirokazu Akashi and Armstrong, {Hilary F.} and Kennel, {Peter J.} and Tiffany Thomas and Forman, {Daniel E.} and Jennifer Hall and Aalap Chokshi and Bartels, {Matthew N.} and Donna Mancini and David Seres and Schulze, {P. Christian}",
year = "2015",
month = "11",
day = "1",
doi = "10.1161/CIRCHEARTFAILURE.115.002073",
language = "English (US)",
volume = "8",
pages = "1077--1087",
journal = "Circulation: Heart Failure",
issn = "1941-3297",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Supplementation of l-Alanyl-l-Glutamine and Fish Oil Improves Body Composition and Quality of Life in Patients With Chronic Heart Failure

AU - Wu, Christina

AU - Kato, Tomoko S.

AU - Ji, Ruiping

AU - Zizola, Cynthia

AU - Brunjes, Danielle L.

AU - Deng, Yue

AU - Akashi, Hirokazu

AU - Armstrong, Hilary F.

AU - Kennel, Peter J.

AU - Thomas, Tiffany

AU - Forman, Daniel E.

AU - Hall, Jennifer

AU - Chokshi, Aalap

AU - Bartels, Matthew N.

AU - Mancini, Donna

AU - Seres, David

AU - Schulze, P. Christian

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Background - Skeletal muscle dysfunction and exercise intolerance are clinical hallmarks of patients with heart failure. These have been linked to a progressive catabolic state, skeletal muscle inflammation, and impaired oxidative metabolism. Previous studies suggest beneficial effects of ω-3 polyunsaturated fatty acids and glutamine on exercise performance and muscle protein balance. Methods and Results - In a randomized double-blind, placebo-controlled trial, 31 patients with heart failure were randomized to either l-alanyl-l-glutamine (8 g/d) and polyunsaturated fatty acid (6.5 g/d) or placebo (safflower oil and milk powder) for 3 months. Cardiopulmonary exercise testing, dual-energy x-ray absorptiometry, 6-minute walk test, hand grip strength, functional muscle testing, echocardiography, and quality of life and lateral quadriceps muscle biopsy were performed at baseline and at follow-up. Oxidative capacity and metabolic gene expression were analyzed on muscle biopsies. No differences in muscle function, echocardiography, 6-minute walk test, or hand grip strength and a nonsignificant increase in peak VO2 in the treatment group were found. Lean body mass increased and quality of life improved in the active treatment group. Molecular analysis revealed no differences in muscle fiber composition, fiber cross-sectional area, gene expression of metabolic marker genes (PGC1α, CPT1, PDK4, and GLUT4), and skeletal muscle oxidative capacity. Conclusions - The combined supplementation of l-alanyl-l-glutamine and polyunsaturated fatty acid did not improve exercise performance or muscle function but increased lean body mass and quality of life in patients with chronic stable heart failure. These findings suggest potentially beneficial effects of high-dose nutritional polyunsaturated fatty acids and amino acid supplementations in patients with chronic stable heart failure.

AB - Background - Skeletal muscle dysfunction and exercise intolerance are clinical hallmarks of patients with heart failure. These have been linked to a progressive catabolic state, skeletal muscle inflammation, and impaired oxidative metabolism. Previous studies suggest beneficial effects of ω-3 polyunsaturated fatty acids and glutamine on exercise performance and muscle protein balance. Methods and Results - In a randomized double-blind, placebo-controlled trial, 31 patients with heart failure were randomized to either l-alanyl-l-glutamine (8 g/d) and polyunsaturated fatty acid (6.5 g/d) or placebo (safflower oil and milk powder) for 3 months. Cardiopulmonary exercise testing, dual-energy x-ray absorptiometry, 6-minute walk test, hand grip strength, functional muscle testing, echocardiography, and quality of life and lateral quadriceps muscle biopsy were performed at baseline and at follow-up. Oxidative capacity and metabolic gene expression were analyzed on muscle biopsies. No differences in muscle function, echocardiography, 6-minute walk test, or hand grip strength and a nonsignificant increase in peak VO2 in the treatment group were found. Lean body mass increased and quality of life improved in the active treatment group. Molecular analysis revealed no differences in muscle fiber composition, fiber cross-sectional area, gene expression of metabolic marker genes (PGC1α, CPT1, PDK4, and GLUT4), and skeletal muscle oxidative capacity. Conclusions - The combined supplementation of l-alanyl-l-glutamine and polyunsaturated fatty acid did not improve exercise performance or muscle function but increased lean body mass and quality of life in patients with chronic stable heart failure. These findings suggest potentially beneficial effects of high-dose nutritional polyunsaturated fatty acids and amino acid supplementations in patients with chronic stable heart failure.

KW - echocardiography

KW - heart failure

KW - metabolism

KW - muscle, skeletal

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=84947804753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947804753&partnerID=8YFLogxK

U2 - 10.1161/CIRCHEARTFAILURE.115.002073

DO - 10.1161/CIRCHEARTFAILURE.115.002073

M3 - Article

C2 - 26269566

AN - SCOPUS:84947804753

VL - 8

SP - 1077

EP - 1087

JO - Circulation: Heart Failure

JF - Circulation: Heart Failure

SN - 1941-3297

IS - 6

ER -